Aspirin Resistance Is Associated with Glycemic Control, the Dose of Aspirin, and Obesity in Type 2 Diabetes Mellitus

201070 citationsJournal Articlebronze Open Access

Authors

Derun Taner Ertuğrul · S.B. Keçiören Eğitim ve Araştırma Hastanesi

Emre Tutal · S.B. Keçiören Eğitim ve Araştırma Hastanesi

Mehmet Yıldız · S.B. Keçiören Eğitim ve Araştırma Hastanesi

Okhan Akın

Ahmet Arif Yalçın · S.B. Keçiören Eğitim ve Araştırma Hastanesi

Öznur Sarı Üre · S.B. Keçiören Eğitim ve Araştırma Hastanesi

Hamıyet Yilmaz · Istanbul Aydın University

Abstract

These data suggest that glycemic control, obesity, and the dose of aspirin have influence on AR in diabetic subjects. Further studies with larger groups are needed to clarify the role of glycemic control on AR.

Topics & Keywords

Antiplatelet Therapy and Cardiovascular Diseases Diabetes Treatment and Management Inflammatory mediators and NSAID effects

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Clinical Endocrinology & Metabolism

Volume 95, Issue 6, pp. 2897-2901

DOI: 10.1210/jc.2009-2392

Field-Weighted Citation Impact: 4.30